Benznidazole FDA Approval History
Last updated by Judith Stewart, BPharm on Sep 7, 2020.
FDA Approved: Yes (First approved August 29, 2017)
Generic name: benznidazole
Dosage form: Tablets
Company: Chemo Research, S. L.
Treatment for: Trypanosomiasis
Benznidazole is an antiprotozoal indicated for the treatment of Chagas disease, or American trypanosomiasis, a parasitic infection caused by Trypanosoma cruzi.
Development timeline for benznidazole
|Aug 29, 2017||Approval FDA Approves Benznidazole as First U.S. Treatment for Chagas Disease|
|Jun 27, 2017||Benznidazole IND for Chagas Disease Receives Clearance by FDA|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.